Smith Michael David Insider Trades

Insider Trading History

Track insider trading activity for Smith Michael David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Proterra
Proterra PTRA
Director
Holding Value $3.29k 49,126 shares
Last Trade
Mar 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.1k 33,407 shares
$1.50
$0.07
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $417k 15,480 shares
Last Trade
May 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 15,480 shares
$9.28
$26.95
Proterra
Proterra PTRA
Director
Holding Value $1.05k 15,719 shares
Last Trade
Mar 08, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$65.1k 8,812 shares
$7.39
$0.07
Proterra
Proterra PTRA
Director
Holding Value $1.64k 24,531 shares
Last Trade
Feb 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$110k 12,626 shares
$8.73
$0.07
Proterra
Proterra PTRA
Director
Holding Value $798 11,905 shares
Last Trade
Nov 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$101k 8,812 shares
$11.45
$0.07
Proterra
Proterra PTRA
Director
Holding Value $207 3,093 shares
Last Trade
Jul 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.1k 3,093 shares
$11.35
$0.07
Proterra- Warrants(15/06/2026)
Proterra- Warrants(15/06/2026) PTRAW
Director
Holding Value $8.23k 3,093 shares
Last Trade
Jul 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.8k 3,093 shares
$3.80
$2.66
ArcLight Clean Transition - Warrants(22/09/2027)
ArcLight Clean Transition - Warrants(22/09/2027) ACTCW
Director
Holding Value $18.9k 3,093 shares
Last Trade
Jul 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9k 3,093 shares
$6.10
$6.10
ArcLight Clean Transition
ArcLight Clean Transition ACTC
Director
Holding Value $56k 3,093 shares
Last Trade
Jul 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56k 3,093 shares
$18.09
$18.09
ArcLight Clean Transition - Warrants(22/09/2027)
ArcLight Clean Transition - Warrants(22/09/2027) ACTCW
Holding Value $1.22M 200,812 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 200,812 shares
$6.10
$6.10
Proterra
Proterra PTRA
Director
Holding Value $13.5k 200,812 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.07
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $0 0 shares
Last Trade
Jun 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$201k 7,500 shares
$26.83
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $609k 22,596 shares
Last Trade
Jun 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 7,500 shares
$26.99
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $202k 7,500 shares
Last Trade
Jun 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$202k 7,500 shares
$26.99
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $943k 35,000 shares
Last Trade
May 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$908k 35,000 shares
$25.95
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $270k 10,014 shares
Last Trade
Apr 28, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$257k 10,014 shares
$25.65
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $811k 30,096 shares
Last Trade
Apr 28, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$257k 10,014 shares
$25.65
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $0 0 shares
Last Trade
Apr 28, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$258k 10,014 shares
$25.76
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $445k 16,500 shares
Last Trade
Feb 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$251k 16,500 shares
$15.21
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Senior Vp, Development
Holding Value $674k 25,000 shares
Last Trade
Dec 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$466k 25,000 shares
$18.65
$26.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up